Reticulon Protein-1C: A New Hope in the Treatment of Different Neuronal Diseases
Related Experiment Video
Updated: May 21, 2026
An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System
Published on: February 17, 2015
Federica Di Sano1, Mauro Piacentini
1Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 00133 Rome, Italy.
Abstract:
Reticulons (RTNs) are a group of membrane proteins localized on the ER and known to regulate ER structure and functions. Several studies have suggested that RTNs are involved in different important cellular functions such as changes in calcium homeostasis, ER-stress-mediated cell death, and autophagy. RTNs have been demonstrated to exert a cancer specific proapoptotic function via the interaction or the modulation of specific proteins. Reticulons have also been implicated in different signaling pathways which are at the basis of the pathogenesis of several neurodegenerative diseases. In this paper we discuss the accumulating evidence identifying RTN-1C protein as a promising target in the treatment of different pathologies such as cancer or neurodegenerative disorders.
Insights
Reticulons (RTNs) are ER-localized proteins influencing cell functions. RTN-1C shows promise as a therapeutic target for cancer and neurodegenerative diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Reticulons (RTNs) are ER-localized membrane proteins.
- RTNs regulate ER structure, calcium homeostasis, ER-stress, and autophagy.
- RTNs are implicated in cancer and neurodegenerative disease pathogenesis.
Purpose of the Study:
- To review the evidence for RTN-1C as a therapeutic target.
- To highlight the role of RTN-1C in cancer and neurodegenerative disorders.
Main Methods:
- Literature review of studies on Reticulons (RTNs).
- Analysis of RTN-1C's role in cellular functions and disease pathways.
Main Results:
- RTNs modulate crucial cellular processes including calcium homeostasis and autophagy.
- RTN-1C exhibits cancer-specific proapoptotic functions.
- RTN-1C is implicated in signaling pathways relevant to neurodegeneration.
Conclusions:
- RTN-1C is a potential therapeutic target for cancer treatment.
- RTN-1C holds promise for treating neurodegenerative diseases.
- Further research into RTN-1C modulation could lead to novel therapies.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:00Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...